William Makis

01/16/2026

01/15/2026

BREAKING NEWS: Cancer Treatment combination that may have SAVED Scott Adams' life has now saved someone else!!

67 year old man in NAMIBIA Stage 4 Prostate Cancer to bones has World's First Treatment combination: Ivermectin, Fenbendazole and PLUVICTO - 9 months later he is CANCER FREE!!

This is the exact treatment combination I urged the Trump Administration to allow Scott Adams to have and I posted a video about it on November 2, 2025.
Of course, I was ignored.

And it is already saving lives - in AFRICA! 🙏💪

If you ever read ONE Cancer Testimonial of mine, make it THIS ONE. 😃

STORY:
67 year old man in NAMIBIA with Stage 4 Prostate Cancer to bones

In March 2025 he started:

Ivermectin 1mg/kg/day
Fenbendazole 1500mg/day
PLUVICTO x 4 Cycles (Lutetium) - done in Cape Town, South Africa

Results after 5 months: CANCER FREE on PET PSMA (highly sensitive test)

From patient:

"He has had a PET scan done on the 20th October and we were very happy to see that no signs of the cancer have been detected"

"Oncologists were pleased with the results"

KEY POINTS:

This is the EXACT treatment combination I suggested could save Scott Adams’ life in early November 2025.

Instead, he was given Pluvicto + Anktiva, a treatment I said would have NO CHANCE of working, and he died two months after this wrong treatment, on January 13, 2026.

Anktiva (Bioshield) is pioneered by billionaire Dr.Patrick Soon-Shiong , a favorite of the Trump Administration, who was a partner with Peter Hotez in developing and distributing COVID-19 Vaccines outside of the United States.

Anktiva was going to stimulate Scott Adams' NK-Cells which were severely damaged by multiple COVID-19 mRNA Vaccines. Scott Adams told us he was severely vaccine injured by the COVID-19 jabs, BUT Dr.Patrick Soon-Shiong didn't listen!

You can't stimulate COVID-19 Vaccine damaged NK-Cells to proliferate, which may be expressing the SPIKE Protein and make things WORSE!

No one understood this and NO ONE CARED.

Scott Adams should have received Ivermectin + Mebendazole + Pluvicto instead and he may have survived, just like this patient in Namibia, who also had Stage 4 Prostate Cancer with bone metastases like Scott Adams, and is now CANCER FREE.

It’s sad that cancer patients in Namibia get superior cancer care compared to millionaire Cancer patients like Scott Adams in California at Kaiser Permanente.

I have the world's largest Ivermectin Cancer Clientele, 7900 and growing!

We are completely destroying the poor results of major Cancer Centers in the United States.

01/13/2026

Would the Cancer Drug Industry allow anything to jeopardize their $200 billion in annual revenue? 🤔

Repurposed drugs like Ivermectin, Mebendazole and Fenbendazole are completely destroying the outcomes of America's largest Cancer Centers.

I have the world's largest Ivermectin Cancer Clientele and Cancer patients who come to me do much better than any outcomes ever seen at MD Anderson, Mayo Clinic, Johns Hopkins, Memorial Sloan Kettering, Dana Farber, etc... William Makis MD

01/13/2026

01/10/2026

BREAKING NEWS: MEBENDAZOLE in Lung Cancer and Breast Cancer TNBC - 2025 Paper by UAE Researchers looks at how Mebendazole enhances Targeted Therapy Drug killing of cancer cells

HIGHLIGHTS:
This paper tested Mebendazole and Gefitinib (Targeted cancer drug that blocks EGFR, a growth signal overactive in some cancers

They tested 2 types of cancer cells:
A549 Cells (Non-small cell Lung Cancer)
MDA-MD-231 (Triple Negative Breast Cancer)

The researchers grew these cells in nutrient-rich broth, then treated them with the drugs alone or together for 2 days

RESULTS:
Both drugs killed cancer cells on their own & killing increased with higher doses.

Combination of MBZ (0.5 µM) + GEF (1 µM) was dramatically better — it wiped out far more cells than either drug alone (down to ~8–15% survival vs. 20–35% with the best single drug).

This suggests the drugs work together synergistically

This strong combo effect happened in both lung cancer and breast cancer cells.

MECHANISMS:

1. MBZ + GEF strongly lowered genes important for cell division and structure (RAN and RCC1) → this messes up cell division and contributes to cell death

2. MBZ + GEF lowered MMP-2 (protein that helps cancer spread/invade tissues)

3. MBZ + GEF lowered IL-1β and IFN-γ (pro-inflammatory signals that can help tumors grow)

4. MBZ + GEF raised IL-6 and TNF-α, possibly helping trigger immune attack on cancer cells

CONCLUSION:

Mebendazole + Gefitinib combination killed cancer cells very effectively while shifting inflammation-related gene activity in ways that might make the tumor more vulnerable to the immune system

Adding Mebendazole increased cancer cell killing to about double that achieved with the Targeted Therapy Drug alone in both Breast Cancer TNBC and Lung Cancer. William Makis MD

01/09/2026

NEW ARTICLE: IVERMECTIN, FENBENDAZOLE and MEBENDAZOLE Testimonial - 68 year old Canadian woman with Stage 4 Endometrial Cancer metastatic to peritoneum reports after 5 months with shrinking tumors

An amazing Endometrial Cancer success story out of Communist Canada! 😃

68 year old Canadian woman with Stage 4 Endometrial Cancer metastatic to peritoneum

In August 2025 she started:

Ivermectin 1mg/kg/day (72mg)
Fenbendazole 1500mg/day

In October 2025 (CT was improving but not every lesion) she added:

Mebendazole 1000mg/day

KEY POINTS:

The peritoneal metastasis shrinkage is 60% from the October to December CT scans.

There is a MYTH floating out there that Ivermectin and Fenbendazole cannot reach tumors in the peritoneum. This is simply untrue.

We are crushing these myths and we are at the cutting edge of Cancer Care. Repurposed drugs are leading the way into the future.

I have the world's largest Ivermectin Cancer Clientele, we are closing in on 8000! 😮

Every attempt to hinder our work and attack Cancer patients who are exercising their "Right to Try" has failed... William Makis

01/08/2026

NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 67 year old Ontario woman with Stage 4 Thyroid Cancer metastatic to bone reports after 7 months with a miraculous PET/CT Scan!

No one has success with Stage 4 Thyroid Cancer. 😉

STORY:
67 year old Ontario woman with Stage 4 Thyroid Cancer metastatic to bone

In March 2025 she started:

Ivermectin 1.5mg/kg/day
Mebendazole 1500mg/day

Results after 7 months:

"Interval complete metabolic response involving previously seen metabolically active lesions in the anterior neck, superior mediastinum and bilateral lungs"

"Near complete response involving L5 vertebral body lesion"

"Previously seen metabolic activity in the right shoulder/deltoid has resolved"

KEY POINTS:

There is published literature on aggressive Thyroid Cancers responding to Mebendazole in particular (2020 Williamson et al)

But to be honest, I don’t know anyone who is helping thyroid cancer patients with repurposed drugs.

This is what you call "the cutting edge of Cancer Research"

I have the world's largest Ivermectin Cancer Clientele

We are revolutionizing Cancer Care!

01/07/2026

NEW RESEARCH: FENBENDAZOLE in CANCER - Inhibition of Cervical Cancer and Cervical Cancer Stem Cells, fantastic May 2025 Paper out of China!

Major new paper shows how Fenbendazole outperforms chemo!! 😃

HIGHLIGHTS:
Tests were done in vitro (test tubes) & in vivo (mice implanted with human tumors)

Goal was to see if Fenbendazole slows cancer growth, stops cells from dividing, kills cancer cells, and shrinks tumors, while also figuring out how it works

Key Findings from Lab Tests (In Vitro)

Cancer Stem Cells were isolated (1-3% of tumor cells) and were pulled out using markers on their surface (CD133 and CD44)

1. Fenbendazole slowed down growth in both Cervical Cancer Cells and Cervical Cancer Stem Cells with stronger effect at higher doses

2. Fenbendazole trapped cells in the “G2/M” stage of their life cycle, preventing division. Did it to both Cancer Cells and Cancer Stem Cells

3. Cell Death - FBZ triggered apoptosis of Cancer cells and Cancer Stem Cells

Key Findings from Animal Tests (In Vivo)

Setup: Female n**e mice (with weak immune systems) got human HeLa cancer cells injected to grow tumors. Once tumors formed, mice were split into groups:

1. untreated,
2. low-dose FBZ (50 mg/kg),
3. high-dose FBZ (100 mg/kg),
4. or cisplatin (standard chemo) as a comparison.

Tumor Shrinkage:

High-dose Fenbendazole significantly slowed tumor growth over 23 days, reducing tumor volume and weight (about 53% inhibition).

Low-dose FBZ had milder effects (41% inhibition).

Cisplatin was stronger (75% inhibition) but caused bad side effects.

Safety:

Fenbendazole mice stayed healthy: no weight loss, normal behavior, eating, and no organ damage (heart, liver).

Cisplatin caused big weight loss and toxicity.

Survival:
Over 80 days, all untreated mice died.

Cisplatin saved 40% of mice.

Both Fenbendazole doses kept 100% of the mice alive (!!) (Commentary: This is absolutely wild)

CONCLUSION:

Fenbendazole inhibits growth of and also kills both Cervical Cancer Cells and tough to kill Cervical Cancer Stem Cells.

Fenbendazole shrunk tumors in mice and extended survival.

Whereas chemo saved 40% of mice (tumor shrinkage was better than Fenben), Fenbendazole saved 100% of mice.

Fenbendazole also kept mice healthy, normal behavior, no weight loss and no organ damage while chemo caused major weight loss and organ toxicity.

There are MAJOR lessons here.

Fenbendazole doesn’t shrink tumors as well as chemo (Cisplatin) did, but 100% of mice survived with Fenben while only 40% survived with chemo due to toxicity.

Fenbendazole treated mice had no organ toxicity (liver, heart) and no weight loss - while chemo treated mice had severe organ toxicity and severe weight loss.

This is the exact opposite of what Oncologists tell their cancer patients to scare them out of trying Fenbendazole!

Fenbendazole needs human Clinical Trials RIGHT NOW

I have the world's largest Ivermectin and Fenbendazole Cancer Clientele - 7900 Cancer patients now! fans William Makis

01/06/2026

BREAKING NEWS: Pfizer and Moderna COVID-19 mRNA Vaccines cause aggressive cancers called "Turbo Cancer"

There are now over 100 published papers on this and the dam is breaking.

I applaud Mr.Kazuhiro Haraguchi , Member of the House of Representatives in Japan and former Minister of Internal Affairs for having the courage to speak out.

I hope more will speak out so the mRNA technology is banned and criminal investigations can finally begin.

Everyone who pushed contaminated mRNA Vaccines, from doctors to scientists to media to politicians should start lawyering up.

Every doctor who tried to cover up the information about COVID-19 Vaccines and links to cancer also needs to lawyer up. William Makis MD William Makis

01/05/2026

NEW ARTICLE: IVERMECTIN - How does Ivermectin inhibit spread of Breast Cancer? 2025 Thailand paper by Rujimongkon et al.

HIGHLIGHTS:

This paper explores whether Ivermectin could be “repurposed” as a potential helper in fighting certain tough-to-treat breast cancers.

Researchers tested Ivermectin on lab-grown breast cancer cells, specifically types that no longer respond to hormone therapies (like tamoxifen or fulvestrant).

KEY FINDINGS:

Ivermectin slows cancer cell growth: It stops these resistant cancer cells from multiplying as quickly.

The effective doses were in a realistic range (micromolar levels, similar to what’s seen in other lab studies), and it worked about as well on resistant cells as on regular breast cancer cells. Normal (non-cancer) breast cells were less affected, suggesting selectivity for cancer cells.

It may help overcome drug resistance: When combined with tamoxifen (a standard hormone therapy), lower doses of tamoxifen still worked, hinting that Ivermectin could make resistant cancers sensitive again.

It reduces cancer spread potential: Cancer spreads (metastasizes) when cells become more mobile and invasive.

Ivermectin blocked the cancer cells’ ability to migrate and invade in lab tests.

It did this partly by reversing “epithelial-mesenchymal transition” (EMT)—a process where cancer cells become more aggressive and spread-prone.

Specifically, Ivermectin lowered levels of proteins like vimentin and snail (which promote spread) and may help restore E-cadherin (which keeps cells stuck together).

The paper focuses on the Wnt signaling pathway, which is often overactive in breast cancer and drives growth and spread.

Ivermectin reduced certain Wnt “signals” (like Wnt5a/b ligands) and a receptor (LRP6), leading to less EMT and potentially slower progression.
The effects were stronger in resistant cells.

The researchers compared Ivermectin to an approved drug palbociclib (Ibrance), used for similar resistant breast cancers, and found Ivermectin was more effective at blocking some spread-related changes in their tests.

CONCLUSION:

These lab results suggest Ivermectin has promising anti-growth and anti-spread effects on hormone-therapy-resistant breast cancer cells, possibly by interfering with the Wnt pathway and EMT.

My Take…

I always get asked - how can Ivermectin possibly treat cancer if it’s an anti-parasitic?

The answer is: Ivermectin is a LOT MORE than just an anti-parasitic.

Ivermectin has extensive anti-neoplastic properties! William Makis MD